Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanya Simuni

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Annals of Clinical and Translational Neurology|September 5, 2020
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patientsRoy N Alcalay, Pavlina Wolf, Ming Sum Ruby Chiang, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled studyTania Nikolcheva, Gennaro Pagano, Judith Anzures-Cabrera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
Human Brain Mapping|August 13, 2019
Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in ParkinsonismTrina Mitchell, Derek B Archer, Winston T Chu, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Journal of Parkinson'S Disease|May 22, 2023
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn M Stebbins, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Neuroimage. Clinical|April 30, 2022
Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyTrina Mitchell, Bradley J Wilkes, Derek B Archer, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Annals of Clinical and Translational Neurology|September 5, 2020
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patientsRoy N Alcalay, Pavlina Wolf, Ming Sum Ruby Chiang, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled studyTania Nikolcheva, Gennaro Pagano, Judith Anzures-Cabrera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2021
Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND StudyWerner Poewe, Fabrizio Stocchi, David Arkadir, et al.
Human Brain Mapping|August 13, 2019
Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in ParkinsonismTrina Mitchell, Derek B Archer, Winston T Chu, et al.
Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Journal of Parkinson'S Disease|May 22, 2023
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn M Stebbins, et al.
Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Neuroimage. Clinical|April 30, 2022
Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyTrina Mitchell, Bradley J Wilkes, Derek B Archer, et al.
Pageof 20